Evidence map›Paper›PMID 38383130›Full record

ArticleBMJ case reports2024

Possible case of bortezomib-induced ileus paralytic.

Nikhil Aravind, Niveditha Krishnappa, Nusrat Shafiq, Pankaj Malhotra

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nikhil AravindPharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Niveditha KrishnappaPharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Nusrat ShafiqPharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pankaj MalhotraHematology, Internal Medicine, PGIMER, Chandigarh, India hematpgi@gmail.com.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes a case of a patient with active multiple myeloma who was started on bortezomib, cyclophosphamide and dexamethasone and subsequently presented to the emergency department with acute intestinal obstruction one week later. The patient underwent exploratory laparotomy, but no mechanical cause of the obstruction was found. The patient later developed sepsis and eventually died. The possible cause of the intestinal obstruction was attributed to bortezomib, and the paper discusses the potential mechanism of this side effect and its management based on available literature.

Indexed as

IleusIntestinal ObstructionMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBortezomibCyclophosphamideDexamethasoneHumansBortezomibCyclophosphamideDexamethasoneChemotherapyHaematology (incl blood transfusion)Malignant and Benign haematologyUnwanted effects / adverse reactions

Identifiers

PMID38383130
PMCPMC10882399
OpenAlexW4392091104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.